Volume 80, Issue 12, Pages (December 2011)

Slides:



Advertisements
Similar presentations
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Has Public Reporting of Hospital Readmission Rates.
Advertisements

Michael J. Koren, MD, Michael H. Davidson, MD, Daniel J
Vitamin D levels and patient outcome in chronic kidney disease
Chronic Kidney Disease in Diabetes
Volume 94, Issue 3, Pages (September 2018)
Chapter 2: Pharmacological cholesterol-lowering treatment in adults
Volume 74, Pages S1-S3 (August 2008)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008  Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,
NSAID Use and Progression of Chronic Kidney Disease
Volume 79, Issue 12, Pages (June 2011)
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort  Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.
Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States  Austin G. Stack, Bhamidipati V.R.
Cardiovascular Disease and CKD: Core Curriculum 2010
Volume 80, Issue 1, Pages (July 2011)
John P. Middleton, Patrick H. Pun  Kidney International 
Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort  Florencia Harari, Gerd Sallsten, Anders Christensson, Marinka Petkovic, Bo.
Volume 80, Issue 2, Pages (July 2011)
Rise or fall of glomerular filtration rate: does it matter?
Volume 78, Issue 8, Pages (October 2010)
Differences in Use of Peritoneal Dialysis and Survival Among East Asian, Indo Asian, and White ESRD Patients in Canada  Brenda R. Hemmelgarn, PhD, MD,
Volume 86, Issue 4, Pages (October 2014)
Your Kidneys May Outlive You
Volume 72, Issue 10, Pages (November 2007)
Volume 79, Pages S9-S13 (April 2011)
Volume 79, Issue 12, Pages (June 2011)
Volume 75, Issue 10, Pages (May 2009)
Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients  Fowzia Ibrahim, MSc, Lisa Hamzah, MRCP, Rachael.
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease  Johannes F.E. Mann, Qi-Long.
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Volume 84, Issue 5, Pages (November 2013)
Aminu K. Bello, Natasha Wiebe, Brenda R. Hemmelgarn, Braden J
Management of Heart Failure in Advancing CKD: Core Curriculum 2018
Volume 68, Issue 5, Pages (November 2005)
CKD and the Risk of Acute, Community-Acquired Infections Among Older People With Diabetes Mellitus: A Retrospective Cohort Study Using Electronic Health.
Volume 79, Issue 9, Pages (May 2011)
Stephen P. McDonald  Kidney International Supplements 
U-shaped effect of eGFR and mortality
Volume 76, Issue 10, Pages (November 2009)
Volume 83, Issue 4, Pages (April 2013)
Beef Tea, Vitality, Creatinine, and the Estimated GFR
Volume 86, Issue 3, Pages (September 2014)
Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House 
Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled RxEACH Trial 
Estimated Glomerular Filtration Rate Within the Normal or Mildly Impaired Range and Incident Cardiovascular Disease  Alon Eisen, MD, Moshe Hoshen, PhD,
Volume 76, Issue 3, Pages (August 2009)
Vitamin D levels and patient outcome in chronic kidney disease
Volume 83, Issue 2, Pages (February 2013)
Methods for guideline development
Volume 76, Issue 8, Pages (October 2009)
Volume 80, Issue 6, Pages (September 2011)
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease  C.P. Kovesdy, S. Ahmadzadeh,
Volume 75, Issue 5, Pages (March 2009)
Volume 85, Issue 5, Pages (May 2014)
Volume 72, Issue 4, Pages (August 2007)
Volume 77, Issue 12, Pages (June 2010)
Volume 82, Issue 3, Pages (August 2012)
Volume 80, Issue 10, Pages (November 2011)
Michael R. Lattanzio, Matthew R. Weir  Kidney International 
Volume 81, Issue 12, Pages (June 2012)
Volume 75, Issue 1, Pages (January 2009)
Volume 74, Issue 3, Pages (August 2008)
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Adiponectin: good, bad, or just plain ugly?
Friends, social networks, and progressive chronic kidney disease
Figure 2. Associations of comorbidities with PD in elderly participants in the multivariate regression analysis. The multivariate Cox proportional-hazards.
Volume 86, Issue 2, Pages (August 2014)
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Increased incidence rate ratio (IRR) and 95% confidence intervals (CI) for type-specific community-acquired infections across eGFR categories within 12.
Presentation transcript:

Volume 80, Issue 12, Pages 1306-1314 (December 2011) Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria  Marcello Tonelli, Scott W. Klarenbach, Anita M. Lloyd, Matthew T. James, Aminu K. Bello, Braden J. Manns, Brenda R. Hemmelgarn  Kidney International  Volume 80, Issue 12, Pages 1306-1314 (December 2011) DOI: 10.1038/ki.2011.280 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Risk of all-cause mortality, by estimated glomerular filtration rate (eGFR) using the MDRD equation (N=920,985). Proteinuria assessed by dipstick urinalysis. This model is fully adjusted for age, sex, diabetes, hypertension, socioeconomic status, and history of cancer, cerebrovascular disease, congestive heart failure, chronic pulmonary disease, dementia, diabetes with end-organ damage, diabetes without chronic complication, AIDS/HIV, metastatic solid tumor, myocardial infarction, mild liver disease, moderate or severe liver disease, paralysis, peptic ulcer disease, peripheral vascular disease, or rheumatic disease. The relative increase in the risk of death associated with higher eGFR was more pronounced in older individuals than for younger individuals (e.g., compared with eGFR of 60–74.9ml/min per 1.73m2, the hazard ratio of eGFR>105ml/min per 1.73m2 was 3.0 (95% confidence interval (CI) 2.8, 3.3) for people aged >60 and 1.9 (95% CI 1.5, 2.4) for people aged <40 years). MDRD, modification of diet in renal disease equation. Kidney International 2011 80, 1306-1314DOI: (10.1038/ki.2011.280) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Risk of all-cause mortality, by estimated glomerular filtration rate (eGFR) using the CKD-EPI equation (N=920,908). Proteinuria assessed by dipstick urinalysis. This model is fully adjusted for age, sex, diabetes, hypertension, socioeconomic status, and history of cancer, cerebrovascular disease, congestive heart failure, chronic pulmonary disease, dementia, diabetes with end-organ damage, diabetes without chronic complication, AIDS/HIV, metastatic solid tumor, myocardial infarction, mild liver disease, moderate or severe liver disease, paralysis, peptic ulcer disease, peripheral vascular disease, or rheumatic disease. The relative increase in the risk of death associated with higher eGFR was more pronounced in older individuals than for younger individuals (e.g., compared with eGFR of 60–74.9ml/min per 1.73m2, the hazard ratio of eGFR>105ml/min per 1.73m2 was 5.3 (95% confidence interval (CI) 4.3, 6.5) for people aged >60 and 1.1 (95% CI 0.8, 1.6) for people aged <40 years). CKD, chronic kidney disease. Kidney International 2011 80, 1306-1314DOI: (10.1038/ki.2011.280) Copyright © 2011 International Society of Nephrology Terms and Conditions